2023 annual financial data
NovaBridge Biosciences 2023 Operating margin
NovaBridge Biosciences 2023 operating margin with verified reported values.
Direct answer
Operating margin was -11,395.09%.
Operating income was -511,162,000 CNY and net income was -1,465,694,000 CNY.
Operating cash flow was Not available.
Get free NovaBridge Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,485,809 CNY
- Operating income
- -511,162,000 CNY
- Net income
- -1,465,694,000 CNY
- Operating cash flow
- Not available